US2019239947A1PendingUtilityA1
Systems and Methods for Hypertension Control
Est. expiryDec 19, 2032(~6.4 yrs left)· nominal 20-yr term from priority
Inventors:Adi Mashiach
A61N 1/36117A61N 1/0551A61N 1/36057A61B 2018/00404A61B 18/1492A61N 1/37223A61N 1/36125A61B 2018/1465A61B 2018/00577A61B 2018/00434
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Systems and methods for hypertension control via energy delivery to one or more nerves affecting blood pressure are provided. Systems may include implantable devices configured for non-contacting neuromodulation. Implantable devices may be configured for intravascular implantation. Systems may also include external devices configured to communicated with implantable neuromodulation devices, Additional systems may include non-implantable devices for delivering modulation energy and ablation energy to one or more nerves affecting blood pressure.
Claims
exact text as granted — not AI-modified1 .- 36 . (canceled)
37 . A device, comprising:
a housing configured for location external to a body of a subject; and at least one processor associated with the housing and configured for electrical communication with a power source; and an antenna associated with the at least one processor; the at least one processor being configured to: communicate with a circuit implanted in a subject's vasculature; and adjust delivery of power from the power source to the implanted circuit based on a dynamic biological condition of the subject.
38 . The device of claim 37 , further comprising a sensor associated with the at least one processor for detecting a subject's hypertension level.
39 . The device of claim 37 , wherein the housing is configured to be worn by a subject and wherein the processor is configured to periodically adjusted delivery of power to the implanted circuit based on detected hypertension level.
40 . The device of claim 37 , wherein the processor is further configured to receive therapy parameters, the therapy parameters including information about a subject's hypertension level.
41 . The device of claim 37 , wherein the dynamic biological condition is associated with a hypertension level.
42 . The device of claim 37 , wherein the dynamic biological condition is associated with Parkinson's Disease, tremors, depression, peripheral vascular disease, angina, claudication, diabetes, renal failure; and erectile dysfunction.
43 - 44 . (canceled)
45 . A device comprising:
an intravascular delivery mechanism configured to deliver an intravascular implant to a location in at least one of a carotid artery and a jugular vein of a subject via at least one of an axillary artery and a jugular vein of the subject, the intravascular implant being removably secured to a distal end of the intravascular delivery mechanism; the intravascular delivery mechanism comprising: a carrier configured for intravascular delivery; at least one electrode arranged for delivery with the carrier, the at least one electrode being configured and tuned to stimulate a glossopharyngeal nerve upon reception of a power signal sent from a location external to the subject's body; and a circuit portion arranged for intravascular delivery with the carrier, the circuit portion being electrically connected to the at least one electrode.
46 . (canceled)
47 . A method of orienting an intravascular device, the method comprising:
delivering the intravascular device to an implant location in vasculature of a subject's body, the intravascular device including a carrier and an antenna; arranging an external antenna outside the body of the subject, the external antenna being electrically connected to a power source; transmitting a wireless signal from the external antenna to the antenna of the intravascular device; detecting a level of coupling between the external antenna and the antenna of the intravascular device; adjusting a relative position of the intravascular device until a level of coupling exceeds a predetermined threshold; and fixing the position of the intravascular device within the vasculature of the subject when the predetermined threshold is exceeded.
48 .- 62 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.